Jared Stephens leads global strategy and corporate development for Nanoscope Therapeutics.  Prior to joining Nanoscope, Dr. Stephens served as Director of Strategy, Search & Evaluation for GE Healthcare with responsibility for inorganic growth strategies across the Cell & Gene Therapy and Genomics business units.  In that capacity, he led multiple deals to bring adjacent high growth technologies into the GE portfolio.

Dr. Stephens has also served in corporate strategy and leadership roles at multiple startups including Absci and Bionano Genomics, both of which conducted initial public offerings and achieved market capitalizations exceeding $1B.  A cell biologist by training, Jared holds a Bachelor of Science in Biochemistry from the University of California, Riverside and a  PhD in Cell and Molecular Biology from the University of California, Irvine.